Dimensional Fund Advisors LP lifted its position in agilon health, inc. (NYSE:AGL – Free Report) by 25.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 255,914 shares of the company’s stock after acquiring an additional 51,852 shares during the period. Dimensional Fund Advisors LP owned 0.06% of agilon health worth $486,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its stake in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after acquiring an additional 1,083,492 shares during the last quarter. Inspire Investing LLC boosted its stake in shares of agilon health by 106.6% in the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock worth $413,000 after acquiring an additional 112,241 shares during the last quarter. Cerity Partners LLC acquired a new stake in shares of agilon health in the fourth quarter worth approximately $34,000. Geode Capital Management LLC boosted its stake in shares of agilon health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock worth $13,168,000 after acquiring an additional 35,207 shares during the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new stake in shares of agilon health in the fourth quarter worth approximately $111,000.
agilon health Stock Performance
Shares of agilon health stock opened at $2.47 on Friday. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The business’s fifty day simple moving average is $4.18 and its 200-day simple moving average is $3.19. The firm has a market cap of $1.02 billion, a PE ratio of -2.62 and a beta of 0.38. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on AGL shares. JMP Securities reissued a “market perform” rating on shares of agilon health in a research note on Monday, April 28th. Barclays boosted their price objective on agilon health from $2.00 to $3.00 and gave the stock an “underweight” rating in a research note on Thursday, May 8th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research note on Friday, March 21st. Royal Bank of Canada boosted their price objective on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Finally, Citigroup raised agilon health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, agilon health currently has an average rating of “Hold” and an average target price of $4.90.
Check Out Our Latest Analysis on AGL
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than agilon health
- Stock Sentiment Analysis: How it Works
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- What Are Earnings Reports?
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- How to Invest in the FAANG Stocks
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.